ES8301197A1 - Un procedimiento para la preparacion de tioeteres. - Google Patents
Un procedimiento para la preparacion de tioeteres.Info
- Publication number
- ES8301197A1 ES8301197A1 ES501496A ES501496A ES8301197A1 ES 8301197 A1 ES8301197 A1 ES 8301197A1 ES 501496 A ES501496 A ES 501496A ES 501496 A ES501496 A ES 501496A ES 8301197 A1 ES8301197 A1 ES 8301197A1
- Authority
- ES
- Spain
- Prior art keywords
- biologically active
- preparing
- therapeutically effective
- active agents
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Cephalosporin Compounds (AREA)
- Furan Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyrrole Compounds (AREA)
- Manufacturing Of Electrical Connectors (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14198180A | 1980-04-21 | 1980-04-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES501496A0 ES501496A0 (es) | 1982-12-01 |
| ES8301197A1 true ES8301197A1 (es) | 1982-12-01 |
Family
ID=22498074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES501496A Expired ES8301197A1 (es) | 1980-04-21 | 1981-04-20 | Un procedimiento para la preparacion de tioeteres. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4443435A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0038541B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPS572252A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE21388T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE3175100D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK172081A (cg-RX-API-DMAC7.html) |
| ES (1) | ES8301197A1 (cg-RX-API-DMAC7.html) |
| GR (1) | GR75219B (cg-RX-API-DMAC7.html) |
| IE (1) | IE52017B1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT72877B (cg-RX-API-DMAC7.html) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK172081A (da) * | 1980-04-21 | 1981-10-22 | Merck & Co Inc | Mercaptoforbindelse og fremgangsmaade til fremstilling deraf |
| JPS57183778A (en) * | 1981-04-30 | 1982-11-12 | Nippon Synthetic Chem Ind Co Ltd:The | S-(3-phthalidyl)-l-cysteine and its preparation |
| US4454065A (en) * | 1982-05-18 | 1984-06-12 | Smithkline Beckman Corporation | Oligopeptide prodrugs |
| DK302883D0 (da) * | 1983-06-30 | 1983-06-30 | Hans Bundgaard | Allopurinol prodrugs |
| CS249576B1 (en) * | 1984-12-22 | 1987-04-16 | Antonin Cerny | 6-purinyl n-(2-chlorethyl)carbamate and thiocarbamate and method of their production |
| WO1986004929A1 (fr) | 1985-02-22 | 1986-08-28 | Kawasaki Steel Corporation | Procede de production de plaques d'acier au silicium unidirectionnelles avec une perte de fer extremement faible |
| US5203928A (en) * | 1986-03-25 | 1993-04-20 | Kawasaki Steel Corporation | Method of producing low iron loss grain oriented silicon steel thin sheets having excellent surface properties |
| JPH0615694B2 (ja) * | 1987-04-17 | 1994-03-02 | 川崎製鉄株式会社 | 方向性けい素鋼板の鉄損低減方法 |
| DE3889600T2 (de) * | 1987-08-01 | 1994-09-01 | Kawasaki Steel Co | Kornorientierte Elektrobleche mit sehr geringen Eisenverlusten und Verfahren zum Herstellen dieser Bleche. |
| US5120740A (en) * | 1989-11-03 | 1992-06-09 | Wisconsin Alumni Research Foundation | Prodrugs of 6-mercaptopurine and 6-thioguanine |
| JPH0723511B2 (ja) * | 1989-12-07 | 1995-03-15 | 新日本製鐵株式会社 | 一方向性電磁鋼帯の処理装置 |
| DE69420058T2 (de) * | 1993-01-12 | 2000-04-27 | Nippon Steel Corp., Tokio/Tokyo | Kornorientiertes Elektroblech mit sehr geringen Eisenverlusten und Herstellungsverfahren |
| US5823679A (en) * | 1993-09-17 | 1998-10-20 | Omega Engineering, Inc. | Method and apparatus for measuring temperature including aiming light |
| FR2773214B1 (fr) | 1996-12-11 | 2002-05-31 | Omega Engineering | Procede et dispositif pour la mesure par infrarouge de la temperature d'une surface |
| DE69810852T2 (de) * | 1997-07-17 | 2003-06-05 | Kawasaki Steel Corp., Kobe | Kornorientiertes Elektrostahlblech mit ausgezeichneten magnetischen Eigenschaften und dessen Herstellungsverfahren |
| KR100586440B1 (ko) | 2001-07-16 | 2006-06-08 | 신닛뽄세이테쯔 카부시키카이샤 | 고자장 철손과 피막 특성이 우수한 초고자속밀도 일방향성전자강판과 그 제조 방법 |
| US8188067B2 (en) | 2004-04-01 | 2012-05-29 | Teva Pharmaceutical Industries Ltd. | Formulations of 6-mercaptopurine |
| CA2560997A1 (en) * | 2004-04-01 | 2005-10-27 | Teva Pharmaceutical Industries Ltd. | Delayed release formulations of 6-mercaptopurine |
| EP2096185B1 (en) | 2006-11-22 | 2014-08-13 | Nippon Steel & Sumitomo Metal Corporation | Unidirectionally grain oriented electromagnetic steel sheet having excellent film adhesion, and method for manufacturing the same |
| WO2008074132A1 (en) | 2006-12-19 | 2008-06-26 | Methylgene Inc. | Inhibitors of histone deacetylase and prodrugs thereof |
| CA2721728A1 (en) * | 2008-04-18 | 2009-10-22 | Teva Pharmaceutical Industries Ltd. | Treatment of inflammatory bowel disease with 6-mercaptopurine |
| JP5923879B2 (ja) | 2010-06-29 | 2016-05-25 | Ｊｆｅスチール株式会社 | 方向性電磁鋼板およびその製造方法 |
| JP5927754B2 (ja) | 2010-06-29 | 2016-06-01 | Ｊｆｅスチール株式会社 | 方向性電磁鋼板およびその製造方法 |
| US9330839B2 (en) | 2010-08-06 | 2016-05-03 | Jfe Steel Corporation | Grain oriented electrical steel sheet and method for manufacturing the same |
| JP5998424B2 (ja) | 2010-08-06 | 2016-09-28 | Ｊｆｅスチール株式会社 | 方向性電磁鋼板 |
| JP5853352B2 (ja) | 2010-08-06 | 2016-02-09 | Ｊｆｅスチール株式会社 | 方向性電磁鋼板およびその製造方法 |
| JP5593942B2 (ja) | 2010-08-06 | 2014-09-24 | Ｊｆｅスチール株式会社 | 方向性電磁鋼板およびその製造方法 |
| RU2576355C1 (ru) | 2011-12-26 | 2016-02-27 | ДжФЕ СТИЛ КОРПОРЕЙШН | Текстурированный лист электротехнической стали |
| KR101638890B1 (ko) | 2011-12-27 | 2016-07-12 | 제이에프이 스틸 가부시키가이샤 | 방향성 전자 강판의 철손 개선 장치 |
| JP5761377B2 (ja) | 2011-12-27 | 2015-08-12 | Ｊｆｅスチール株式会社 | 方向性電磁鋼板 |
| CN104024455B (zh) | 2011-12-28 | 2016-05-25 | 杰富意钢铁株式会社 | 方向性电磁钢板及其铁损改善方法 |
| US10804015B2 (en) | 2011-12-29 | 2020-10-13 | Posco | Electrical steel sheet and method for manufacturing the same |
| WO2013160955A1 (ja) | 2012-04-26 | 2013-10-31 | Ｊｆｅスチール株式会社 | 方向性電磁鋼板およびその製造方法 |
| JP5971157B2 (ja) | 2013-03-11 | 2016-08-17 | Ｊｆｅスチール株式会社 | 塗布装置および塗布方法 |
| JP5668795B2 (ja) | 2013-06-19 | 2015-02-12 | Ｊｆｅスチール株式会社 | 方向性電磁鋼板およびそれを用いた変圧器鉄心 |
| CN105555984B (zh) | 2013-09-19 | 2017-07-07 | 杰富意钢铁株式会社 | 方向性电磁钢板及其制造方法 |
| JP6215673B2 (ja) | 2013-11-29 | 2017-10-18 | 東芝産業機器システム株式会社 | ベクトル磁気特性制御材、および、鉄心 |
| KR101639920B1 (ko) | 2014-12-26 | 2016-07-15 | 주식회사 포스코 | 방향성 전기강판의 자구미세화 장치 및 그 방법 |
| WO2017066619A1 (en) | 2015-10-16 | 2017-04-20 | Teva Pharmaceutical Industries Ltd. | Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine |
| CA3054528C (en) | 2017-02-28 | 2021-09-07 | Jfe Steel Corporation | Grain-oriented electrical steel sheet and production method therefor |
| KR102880080B1 (ko) | 2020-11-27 | 2025-10-31 | 제이에프이 스틸 가부시키가이샤 | 방향성 전자 강판 및 그의 제조 방법 |
| CN115724824B (zh) * | 2021-09-01 | 2024-03-15 | 四川大学 | 3-(酰胺烷硫基)苯酞类化合物、其制备方法和用途 |
| KR20240113807A (ko) | 2022-01-06 | 2024-07-23 | 제이에프이 스틸 가부시키가이샤 | 방향성 전자 강판 |
| EP4582567A4 (en) | 2022-09-09 | 2025-12-24 | Jfe Steel Corp | GRAIN-ORIENTED ELECTROMAGNETIC STEEL SHEET |
| KR20240098941A (ko) | 2022-12-21 | 2024-06-28 | 주식회사 포스코 | 방향성 전기강판 및 그 제조방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2852506A (en) * | 1955-10-31 | 1958-09-16 | American Cyanamid Co | Method of preparing aminodeoxyglycosidopurines |
| US2844576A (en) * | 1955-11-22 | 1958-07-22 | American Cyanamid Co | Preparation of purines |
| BE733669A (cg-RX-API-DMAC7.html) * | 1968-06-04 | 1969-11-27 | ||
| US3915958A (en) * | 1972-05-22 | 1975-10-28 | Icn Pharmaceuticals | 6-Substituted purine nucleotides |
| JPS49117479A (cg-RX-API-DMAC7.html) * | 1973-05-30 | 1974-11-09 | ||
| US3957803A (en) * | 1975-01-06 | 1976-05-18 | Interx Research Corporation | Certain transient pro-drug forms of phenylbutazone |
| US4275064A (en) * | 1976-02-06 | 1981-06-23 | Interx Research Corporation | Transient pro-drug forms of xanthine derivatives and their use as topical anti-inflammatory agents |
| US4061753A (en) * | 1976-02-06 | 1977-12-06 | Interx Research Corporation | Treating psoriasis with transient pro-drug forms of xanthine derivatives |
| US4235887A (en) * | 1977-04-13 | 1980-11-25 | The Upjohn Company | Process for therapeutic treatment |
| JPS5589257A (en) * | 1978-12-22 | 1980-07-05 | Kanebo Ltd | New easily-absorbable sulfur-containing prodrug of non- steroidal antiphlogistic, and their drug compositions |
| NZ196349A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered polar bioactive agents |
| DK172081A (da) * | 1980-04-21 | 1981-10-22 | Merck & Co Inc | Mercaptoforbindelse og fremgangsmaade til fremstilling deraf |
-
1981
- 1981-04-15 DK DK172081A patent/DK172081A/da not_active IP Right Cessation
- 1981-04-15 GR GR64699A patent/GR75219B/el unknown
- 1981-04-16 IE IE869/81A patent/IE52017B1/en not_active IP Right Cessation
- 1981-04-16 PT PT72877A patent/PT72877B/pt not_active IP Right Cessation
- 1981-04-16 DE DE8181102940T patent/DE3175100D1/de not_active Expired
- 1981-04-16 EP EP81102940A patent/EP0038541B1/en not_active Expired
- 1981-04-16 AT AT81102940T patent/ATE21388T1/de active
- 1981-04-20 ES ES501496A patent/ES8301197A1/es not_active Expired
- 1981-04-21 JP JP5933581A patent/JPS572252A/ja active Granted
- 1981-11-12 US US06/320,264 patent/US4443435A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS572252A (en) | 1982-01-07 |
| GR75219B (cg-RX-API-DMAC7.html) | 1984-07-13 |
| ES501496A0 (es) | 1982-12-01 |
| PT72877A (en) | 1981-05-01 |
| US4443435A (en) | 1984-04-17 |
| EP0038541B1 (en) | 1986-08-13 |
| IE52017B1 (en) | 1987-05-27 |
| JPH0226630B2 (cg-RX-API-DMAC7.html) | 1990-06-12 |
| ATE21388T1 (de) | 1986-08-15 |
| EP0038541A1 (en) | 1981-10-28 |
| DK172081A (da) | 1981-10-22 |
| PT72877B (en) | 1983-03-29 |
| DE3175100D1 (en) | 1986-09-18 |
| IE810869L (en) | 1982-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8301197A1 (es) | Un procedimiento para la preparacion de tioeteres. | |
| ES483767A1 (es) | Procedimiento para producir n-arilsulfonil-l-argininamidas | |
| IS2657A7 (is) | Ný samsetning efnis | |
| ES8303360A1 (es) | Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina. | |
| ES8603501A1 (es) | Un procedimiento para preparar un derivado de 1,8-naftiridina | |
| ES450643A1 (es) | Procedimiento para la preparacion de derivados de pirrolidi-na. | |
| ES485274A1 (es) | Un procedimiento para la preparacion de derivados de fenil- piperacina | |
| ATE1814T1 (de) | 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung. | |
| AR015994A1 (es) | Derivados de cetolidos 2-halo-6-o-sustituidos, composiciones farmaceuticas que los contienen, su uso para la manufactura de un medicamento y procesos parasu preparacion | |
| ES510585A0 (es) | Procedimiento para preparar n-heterociclilmetilamidas. | |
| ES8500244A1 (es) | "un procedimiento para preparar derivados de pirazinona" | |
| SE8604950L (sv) | Demensforbettrande och terapeutiska medel | |
| KR890011838A (ko) | 16-데하이드로 비타민d₃-유도체 | |
| ES8707970A1 (es) | Procedimiento para la obtencion de nuevos derivados de la pristinamicina ii b | |
| FR2361400A1 (fr) | Nouveaux analogues sulfures de penicillines et de cephalosporines, leur procede de preparation et composition pharmaceutique les contenant | |
| ES8405013A1 (es) | Procedimiento para preparar derivados de tieno-tiazol | |
| ES451135A1 (es) | Procedimiento para la preparacion de nuevos compuestos hete-rociclicos conteniendo azufre. | |
| BE872575A (fr) | Compositions de revetement par electrodeposition cathodique contenant des derives d'acides gras | |
| PT76861B (fr) | Procede de preparation de nouveaux derives d'oxazinobenzothiazine-6,6-dioxide et de compositions pharmaceutiques les contenant | |
| FR2374296A1 (fr) | Derives de l'acide phtalique porteurs de groupes alcenylamino | |
| FI810632L (fi) | 5,6:8,9-tetrahydro-7h-dibenz (d f)azoninderivat deras framstaellning och foereningar innehaollande dem | |
| ES8401761A1 (es) | Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos. | |
| ES8702392A1 (es) | Un procedimiento para preparar compuestos heterociclicos, en particular compuestos con un anillo de tiadiazinona | |
| ES8603441A1 (es) | Procedimiento para preparar un derivado de fenotiazina | |
| ATE43594T1 (de) | 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970303 |